Telemetry Investments’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$223K	Sell	57,500 -15,000	-21%	-$46.3K	0.52%	69
2022 Q3	$176K	Sell	72,500 -27,500	-28%	-$66K	0.29%	105
2022 Q2	$198K	Sell	100,000 -132,500	-57%	-$261K	0.3%	105
2022 Q1	$425K	Sell	232,500 -27,500	-11%	-$42.9K	0.68%	54
2021 Q4	$367K	Buy	260,000 +200,000	+333%	+$263K	0.48%	72
2021 Q3	$68K	Buy	+60,000	New	+$84K	0.09%	140
2021 Q1	–	Sell	-200,615	Closed	-$391K	–	127
2020 Q4	$391K	Buy	200,615 +4,000	+2%	+$8.41K	0.72%	57
2020 Q3	$470K	Sell	196,615 -83,526	-30%	-$229K	1.11%	42
2020 Q2	$821K	Sell	280,141 -10,620	-4%	-$30.5K	2.48%	12
2020 Q1	$837K	Buy	290,761 +138,761	+91%	+$480K	3.29%	7
2019 Q4	$608K	Buy	152,000 +88,000	+138%	+$384K	2.12%	19
2019 Q3	$285K	Sell	64,000 -47,005	-42%	-$196K	0.89%	34
2019 Q2	$430K	Buy	+111,005	New	+$490K	0.86%	49
2016 Q4	–	Sell	-10,000	Closed	-$72K	–	104
2016 Q3	$72K	Sell	10,000 -40,000	-80%	-$254K	0.08%	107
2016 Q2	$298K	Buy	50,000 +3,000	+6%	+$21K	0.32%	69
2016 Q1	$380K	Buy	47,000 +2,000	+4%	+$11.4K	0.34%	70
2015 Q4	$365K	Sell	45,000 -1,987	-4%	-$17.9K	0.23%	91
2015 Q3	$393K	Sell	46,987 -33,900	-42%	-$313K	0.22%	90
2015 Q2	$749K	Buy	80,887 +3,587	+5%	+$31K	0.47%	64
2015 Q1	$758K	Buy	77,300 +10,234	+15%	+$103K	0.57%	49
2014 Q4	$749K	Buy	+67,066	New	+$767K	0.54%	59

Other funds holding ADMA